The association between regional arterial stiffness and diabetic retinopathy in type 2 diabetes

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 237-241

  Kim, Won Jun ^a   Park, Cheol Young ^b   Park, Se Eun ^b   Rhee, Eun Jung ^b   Lee, Won Young ^b   Oh, Ki Won ^b   Park, Sung Woo ^b   Kim, Sun Woo ^b   Song, SuJeong ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Arterial stiffness; Atherosclerosis; Diabetic retinopathy; Pulse wave velocity; Type 2 diabetes

Indexed keywords

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CAROTID ARTERY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FEMORAL ARTERY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSE WAVE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; ANKLE BRACHIAL INDEX; BRACHIAL ARTERY; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84867888689     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.08.034     Document Type: Article

References (25)

1. Laurent S., Cockcroft J., Van Bortel L., et al. European network for non-invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27(21):2588-2605.
2. London G.M. Large artery function and alterations in hypertension. J Hypertens 1995, 13(2):S35-S38.
3. Moritani T., Crouse S.F., Shea C.H., Davidson N., Nakamura E. Arterial pulse wave velocity, Fourier pulsatility index, and blood lipid profiles. Med Sci Sports Exerc 1987, 19(4):404-409.
4. London G.M., Marchais S.J., Safar M.E., et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990, 37(1):137-142.
5. Shoji T., Nishizawa Y., Kawagishi T., et al. Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am SocNephrol 1998, 9(7):1277-1284.
6. Taniwaki H., Kawagishi T., Emoto M., et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care 1999, 22(11):1851-1857.
7. Kimoto E., Shoji T., Shinohara K., et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 2003, 52(2):448-452.
8. Tsuchikura S., Shoji T., Kimoto E., et al. Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease. Atherosclerosis 2010, 211(2):480-485.
9. Aso K., Miyata M., Kubo T., et al. Brachial-ankle pulse wave velocity is useful for evaluation of complications in type 2 diabetic patients. Hypertens Res 2003, 26(10):807-813.
10. Cardoso C.R., Ferreira M.T., Leite N.C., Barros P.N., Conte P.H., Salles G.F. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 2009, 205(2):472-476.
11. Park C.Y., Park S.E., Bae J.C., et al. Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul Metropolitan City-Diabetes Prevention Program (SMC-DPP) participants. Br J Ophthalmol 2012, 96(2):151-155.
12. Chen M.S., Kao C.S., Fu C.C., Chen C.J., Tai T.Y. Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int J Epidemiol 1995, 24(4):787-795.
13. Suzuki E., Kashiwagi A., Nishio Y., et al. Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diabetes Care 2001, 24(12):2107-2114.
14. Kim J.S., Kang T.S., Kim J.B., et al. Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients. Atherosclerosis 2007, 192(2):401-406.
15. Munakata M., Ito N., Nunokawa T., Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003, 16(8):653-657.
16. Early Treatment Diabetic Retinopathy Study Research Group Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. Ophthalmology 1991, 98(5 Suppl.):786-806.
17. Ogawa O., Hayashi C., Nakaniwa T., Tanaka Y., Kawamori R. Arterial stiffness is associated with diabetic retinopathy in type 2 diabetes. Diab Res ClinPract 2005, 68(2):162-166.
18. Ogawa O., Hiraoka K., Watanabe T., et al. Diabetic retinopathy is associated with pulse wave velocity, not with the augmentation index of pulse waveform. CardiovascDiabetol 2008, 7(11).
19. Tsuchikura S., Shoji T., Kimoto E., et al. Brachial-ankle pulse wave velocity as an index of central arterial stiffness. J AtherosclerThromb 2010, 17(6):658-665.
20. Kim J.H., Oh S.J., Lee J.M., et al. The effect of an angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension. Diabetes Metab J 2011, 35(3):236-242.
21. Juutilainen A., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 2007, 30(2):292-299.
22. Targher G., Bertolini L., Zenari L., et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabet Med 2008, 25(1):45-50.
23. Safar M.E., London G.M. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European society of hypertension. The clinical committee of arterial structure and function. Working group on Vascular Structure and function of the European society of hypertension. J Hypertens 2000, 18(11):1527-1535.
24. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37(5):1236-1241.
25. Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 2007, 25(6):1105-1187.